Drug Pipeline
Psoriasis
Psoriatic Arthritis| Pre-clinical | Phase I | Phase II | Phase III | To Patients |
|---|
| Pre-clinical | Phase I | Phase II | Phase III | To Patients |
|---|
| Prurisol |
| XP23829 |
| KD025 |
| Alitretinoin |
| Apo805K1 |
| FP187 |
| LEO 22811 |
| Baricitinib (Ly3009104/INCB28050) |
| VB-201 |
| Otezla (apremilast) |
| Piclidenoson (CF101) |
| Tofacitinib (CP-690,550) |
| ZPL-389 |
| VTP-43742 |
| LAS41008 |
| Pre-clinical | Phase I | Phase II | Phase III | To Patients |
|---|
Get the latest research news and tips on managing your psoriasis and psoriatic arthritis.